Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF DECEMBER 02, 2023 SAM #8040
SPECIAL NOTICE

65 -- Chemistry and Special Chemistry testing

Notice Date

11/30/2023 3:27:01 PM
 

Notice Type

Special Notice
 

NAICS

325413 — In-Vitro Diagnostic Substance Manufacturing
 

Contracting Office

DEFENSE HEALTH AGENCY SAN ANTONIO TX 78230 USA
 

ZIP Code

78230
 

Solicitation Number

HT940824R0001
 

Response Due

12/11/2023 10:00:00 AM
 

Archive Date

12/26/2023
 

Point of Contact

Carolynn Benn, Phone: 2108684971, David Erpelding
 

E-Mail Address

carolynn.j.benn.civ@health.mil, david.k.erpelding.civ@health.mil
(carolynn.j.benn.civ@health.mil, david.k.erpelding.civ@health.mil)
 

Description

The Southern Markets Contracting Division (SMCD), San Antonio, Texas, intends to award a firm-fixed-price (FFP) sole source contract to Siemens Healthcare Diagnostics of Tarrytown, New York to conduct Chemistry and Special Chemistry testing for Keesler Medical Center, Keesler Air Force Base, Mississippi. As a Cost-per-Reportable-Test (CPRT) vehicle, the contractor also provides all equipment, consumables, and services necessary to perform the required testing. The contract will be awarded under the authority of Federal Acquisition Regulation (FAR) 13.501. The applicable NAICS code for this requirement is 325413, In-Vitro Diagnostics Substance Manufacturing. The Small Business Size Standard is 1,250 employees. Siemens Healthcare Diagnostics is an ""other-than-small business."" The contract will be awarded on or before 1 January 2024. NOTE: This contract will be issued for a performance period of 1 January 2024 -30 September 2024, with one (1) twelve-month option period. The Government intends to issue a competitive solicitation on a full-and-open basis for these tests, with full performance on the resultant contract to start in FY 2026. This notice is not a request for competitive quotes. All responsible sources may submit a capability statement, which shall be considered by the agency before the intended award date to determine if any other entity is capable of performing the required testing. Interested sources who submit data are responsible for appropriately marking information if it is proprietary in nature. In order for the Government to consider another source, the capability statement must demonstrate the source's ability to 1) provide the required testing; 2) deliver, install, and validate the analyzer(s) to ensure patient-ready testing; and 3) ability to connect to the Defense Health Agency/Military Health System network. The Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored as a result of this notice and any information provided will not be used as part of any subsequent solicitation requirement. No telephonic inquires will be honored. A determination by the Government not to compete with this proposed contract based upon responses to this notice is solely within the discretion of the Government. NOTE: INTERESTED VENDORS MUST RESPOND TO THIS NOTICE TO THE BELOW POCs ON OR BEFORE 11 DECEMBER 2023 BY NOON CENTRAL TIME IN ORDER TO BE CONSIDERED.
 

Web Link

SAM.gov Permalink
(https://sam.gov/opp/ec17a44e13b34911bccab27284e1f023/view)
 

Place of Performance

Address: Biloxi, MS 39534, USA

Zip Code: 39534

Country: USA
 

Record

SN06898670-F 20231202/231130230045 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |